- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: ASP1585
Total 88 results
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of ASP1585United States
-
Astellas Pharma IncCompletedChronic Kidney Disease Patients on Hemodialysis With HyperphosphatemiaJapan
-
Astellas Pharma IncCompletedRenal Insufficiency | Chronic Kidney Disease | HyperphosphatemiaJapan
-
Astellas Pharma IncCompletedRenal Insufficiency | Chronic Kidney Disease | Hyperphosphatemia | Renal DialysisJapan
-
Astellas Pharma IncCompletedA Phase 3 Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Peritoneal DialysisRenal Insufficiency | Chronic Kidney Disease | Renal DialysisJapan
-
Astellas Pharma IncCompletedA Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on DialysisRenal Insufficiency | Chronic Kidney Disease | HyperphosphatemiaJapan
-
Astellas Pharma IncCompletedHealthy | Urine Phosphorus ExcretionJapan
-
Astellas Pharma IncCompletedChronic Renal Failure Patients With Hyperphosphataemia Receiving HemodialysisJapan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedChronic Kidney DiseaseJapan
-
Astellas Pharma IncFibroGenCompletedChronic Kidney DiseaseJapan
-
Astellas Pharma IncFibroGenCompletedESA-naive Hemodialysis Chronic Kidney Disease Patients With AnemiaJapan
-
Astellas Pharma IncFibroGenCompletedPeritoneal Dialysis Chronic Kidney Disease Patients With AnemiaJapan
-
Astellas Pharma IncFibroGenCompleted
-
Astellas Pharma IncFibroGenCompletedHemodialysis Patients With Renal AnemiaJapan
-
Astellas Pharma Europe B.V.FibroGenCompletedImpaired Renal Function | Normal Renal FunctionGermany, United Kingdom
-
Astellas Pharma Global Development, Inc.TerminatedAcute Myeloid LeukemiaCanada, United States
-
Astellas Pharma IncCompletedAnemia in Chronic Kidney Disease Patients Not on DialysisJapan
-
Astellas Pharma Global Development, Inc.FibroGenCompletedHealthy Adult SubjectsGermany
-
Astellas Pharma IncCompletedAnemia | Hemodialysis | Renal ImpairmentJapan
-
Astellas Pharma IncActive, not recruiting
-
Astellas Pharma IncFibroGenCompleted
-
OHSU Knight Cancer InstituteAstellas Pharma US, Inc.; Oregon Health and Science UniversityActive, not recruitingCastration-Resistant Prostate Carcinoma | Metastatic Malignant Neoplasm in the Bone | Metastatic Malignant Neoplasm in the Soft Tissues | Recurrent Prostate Carcinoma | Metastatic Prostate Adenocarcinoma | Stage III Prostate Adenocarcinoma AJCC v7 | Stage IV Prostate Adenocarcinoma AJCC v7United States
-
Astellas Pharma IncCompletedHealthy VolunteersJapan
-
Northwestern UniversityAstellas Pharma IncTerminatedA Pilot Study to Assess the Safety and Efficacy of Alefacept in de Novo Kidney Transplant RecipientsTransplant; Failure, KidneyUnited States
-
Astellas Pharma IncFibroGenCompleted
-
Astellas Pharma IncCompletedA Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on HemodialysisChronic Kidney Disease | HyperphosphatemiaJapan
-
Astellas Pharma IncMedivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedCastration-Resistant Prostate Cancer (CRPC)United States, Moldova, Republic of, South Africa
-
Astellas Pharma IncCompletedRenal Insufficiency | Chronic Kidney Disease | Renal DialysisJapan
-
Astellas Pharma IncFibroGenCompletedHemodialysis Chronic Kidney Disease Patients With AnemiaJapan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of EnalaprilJapan
-
University of WashingtonNational Cancer Institute (NCI); National Comprehensive Cancer NetworkTerminatedRecurrent Mantle Cell Lymphoma | Refractory Mantle Cell Lymphoma | Ann Arbor Stage I Mantle Cell Lymphoma | Ann Arbor Stage II Mantle Cell Lymphoma | Ann Arbor Stage III Mantle Cell Lymphoma | Ann Arbor Stage IV Mantle Cell LymphomaUnited States
-
Astellas Pharma Europe B.V.FibroGenCompletedHepatic Insufficiency | Healthy Subjects | PK of FG-4592Bulgaria
-
Astellas Pharma Europe B.V.Medivation, Inc.CompletedSevere Hepatic Impairment | Normal Hepatic FunctionBulgaria
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of AtorvastatinJapan
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)TerminatedClear Cell Renal Cell Carcinoma | Stage I Renal Cell CancerUnited States
-
Astellas Pharma Global Development, Inc.Medivation, Inc.TerminatedMetastatic Castration Resistant Prostate CancerUnited States
-
Astellas Pharma Europe B.V.FibroGenCompletedHealthy Subjects | Pharmacokinetics of FG-4592Germany
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of ValsartanJapan
-
OHSU Knight Cancer InstituteUnited States Department of Defense; Oregon Health and Science UniversityCompletedCastration-Resistant Prostate Carcinoma | Prostate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | PSA Progression | Castration Levels of TestosteroneUnited States
-
Astellas Pharma IncCompletedRenal Anemia Associated With Chronic Renal Failure (CRF)Japan
-
Astellas Pharma IncBiogenCompleted
-
Astellas Pharma Global Development, Inc.RecruitingChronic Kidney Disease | Renal AnemiaRomania, Spain, Belgium, Germany, Norway, Slovakia
-
Astellas Pharma IncFibroGenCompletedChronic Kidney DiseaseJapan
-
Astellas Pharma IncCompletedPsoriasisUnited States, Bulgaria, Latvia
-
Astellas Pharma IncTerminated
-
Astellas Pharma IncCompletedPharmacokinetics of AlefaceptUnited States
-
Astellas Pharma Europe B.V.FibroGenCompletedHealthy Subjects | PK for FG-4592Germany
-
Astellas Pharma IncBiogenCompletedPsoriasisBelgium, Spain, Germany, United States, France, Canada, Denmark, Netherlands, United Kingdom